Whole-genome landscape of pancreatic neuroendocrine tumours.
about
Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.Loss of the chromatin modifier Kdm2aa causes BrafV600E-independent spontaneous melanoma in zebrafish.Twenty years of menin: emerging opportunities for restoration of transcription in MEN1.The Long Non-Coding RNA MEG3 is an Epigenetic Determinant of Oncogenic Signaling in Functional Pancreatic Neuroendocrine Tumor Cells.A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors.Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas.Classification of pulmonary neuroendocrine tumors: new insights.Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors.Comprehensive Analysis of Hypermutation in Human Cancer.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability.Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma.Succinate dehydrogenase (SDH)-deficient neoplasia.The future: genetics advances in MEN1 therapeutic approaches and management strategies.Cyto-histology in NET: what is necessary today and what is the future?Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.Biology and evolution of poorly differentiated neuroendocrine tumors.Molecular characterisation of metastatic pancreatic neuroendocrine tumours (PNETs) using whole genome and transcriptome sequencing.Genomic landscape of pancreatic neuroendocrine tumours: The International Cancer Genome Consortium.TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias.Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours.Molecular challenges of neuroendocrine tumors.Well differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: A morphologic study.Functional Defects From Endocrine Disease-Associated Mutations in HLXB9 and Its Interacting Partner, NONO.Management of functional neuroendocrine tumors of the pancreas.Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers.Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.Loss of Chromatin Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.Telomere sequence content can be used to determine ALT activity in tumours.Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection.The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer.Uncovering the heterogeneous genetic variations in two insulin-expressing tumors in a patient with MEN1.Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift.Telomere Maintenance Mechanisms in Cancer.
P2860
Q33737472-64629369-3BCC-49A9-8C3A-5051DFE6B000Q38625634-4874B316-DD83-436B-B79D-075F0B3B2071Q38642042-0BD1F917-3BC3-44F7-89FB-F7F0A17150C0Q38694016-5167DF9A-DCC6-4857-8C00-AE3953353FF3Q41127338-90837915-F36C-4F42-BAE1-35F31FC19FEEQ42282703-934E4031-085A-46A3-B656-C1A1D79779D5Q45140096-B0953D09-2DBF-442B-B934-06E1149FF43DQ45890813-5CB0D504-91A3-4D8C-9FA8-F7C77E05209FQ46592106-E6964288-B474-4B43-A1BF-16F0BAFC6668Q47128709-714F812C-2A5F-46EC-A64A-9F96B38F839CQ47164606-AE76A517-4314-4E66-98B7-7C4B81D1649EQ47170689-7E18DD64-4C55-4A31-8D86-B8E9766A3C66Q47557041-B3FC0121-133C-4CC9-A731-A4F4FBE51D9BQ47680883-5F7D0EFC-4B92-48B7-AE2E-74DB91DBFF15Q47814736-F57F573C-98C1-4ED7-A220-5FC838196CA9Q47965331-83FFB75C-3573-4519-A6C0-62888E108B3AQ48120139-A65254B9-AD93-4F3E-9679-B69655B2DA98Q48295398-EBE7BA75-1280-4564-9F08-8D86BF5E06E2Q48320507-CB0933CA-2912-44D6-94F9-753B4B9C3053Q48380432-B180CE1F-2651-4A42-AA20-A001F20274E4Q48520101-C0ECB5FB-7FB6-48ED-98B6-64162E643553Q49318644-FFF0DEBD-D6C6-4F7F-BD64-3B873EF5962CQ49612106-E7E060CF-9422-48E0-9766-5C86DD979CE7Q49720507-1DDC87AE-F5A3-4975-9F91-5A8AAB0E4A16Q49875027-A6D94589-2061-4007-B8E8-FC84A61840A2Q49928150-55662C12-EFCC-404E-BA5C-D3360F0B339EQ50138607-63F2A6BA-922B-4EF3-B835-BCF7B25D6199Q52599451-000211F1-9CBC-4A59-B75E-D409890E78BCQ52609129-5879A389-2E17-43CF-9BBB-AA44C0F62D10Q52625303-131EAE3D-CDCF-42C6-B230-33297BE93629Q52688905-247E0949-7DE9-4B47-A9FB-3B9122A5FA9AQ52714796-66F8CB84-1511-4D80-A614-D355B0C27455Q54094414-15FAA20C-1055-48F2-899A-C16E8466BE60Q54122937-0EA9D00A-DC29-43A2-A393-02DB885D4056Q54976476-ED4452D4-429E-4163-896D-A2B94F79720FQ55002164-4D8B4540-CFD3-4195-A471-91221590B0CAQ55104265-CF1CE4A4-BB15-45B4-BFB7-53B8ACE95107Q55260441-C83069CF-0531-49BD-8140-CB7D0F6A35C4Q55313360-3A162653-04F0-4FB4-BB26-E0621EDCE312Q55443450-645EDDFF-B66B-411F-89BE-F3DFFF000E85
P2860
Whole-genome landscape of pancreatic neuroendocrine tumours.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Whole-genome landscape of pancreatic neuroendocrine tumours.
@en
Whole-genome landscape of pancreatic neuroendocrine tumours.
@nl
type
label
Whole-genome landscape of pancreatic neuroendocrine tumours.
@en
Whole-genome landscape of pancreatic neuroendocrine tumours.
@nl
prefLabel
Whole-genome landscape of pancreatic neuroendocrine tumours.
@en
Whole-genome landscape of pancreatic neuroendocrine tumours.
@nl
P2093
P2860
P50
P356
P1433
P1476
Whole-genome landscape of pancreatic neuroendocrine tumours
@en
P2093
Adnan M Nagrial
Aldo Scarpa
Amanda Mawson
Amber L Johns
Andrea Mafficini
Andrew Barbour
Angela Chou
Angelika N Christ
Anna Malpaga
Anthony J Gill
P2860
P2888
P356
10.1038/NATURE21063
P407
P50
P577
2017-02-15T00:00:00Z